Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bentue-Ferrer

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
La Nouvelle Presse Medicale|June 28, 1980
[Does bromocriptine act through the autonomic nervous system?]H Allain, D Bentue-Ferrer, D Pape, et al.
Neuropsychobiology|January 1, 1996
The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the ratM A Caldwell, J M Reymann, D Bentue-Ferrer, et al.
Revue Neurologique|January 17, 2003
[Mild Cognitive Impairment: potential therapeutics]H Allain, D Bentue-Ferrer, S Belliard, et al.
Fundamental & Clinical Pharmacology|January 1, 1991
Cardiac beta-adrenoceptor sensitivity and Parkinson's diseaseD Milon, H Allain, D Bentue-Ferrer, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1994
Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free mediumB Saïag, D Milon, D Bentue-Ferrer, et al.
Psychopharmacology|January 1, 1980
The use of bromocriptine for testing central dopaminergic reactivityH Allain, J M Reymann, D Bentue-Ferrer, et al.
Presse Medicale (Paris, France : 1983)|June 18, 1987
[Cerebral edema: intra-cellular or extra-cellular mechanisms?]H Allain, D Bentue-Ferrer, H Bagot, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|February 8, 1980
[Drugs and indications for medical treatment in Parkinson's disease (author's transl)]H Allain, J Van den Driessche, F Menault, et al.
Psychopharmacology|March 22, 1979
Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC)H Allain, J Van den Driessche, D Bentue-Ferrer, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Comparative evaluation of scavenger properties of exifone, piracetam and vinburnineD Bentue-Ferrer, V Philouze, D Pape, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
La Nouvelle Presse Medicale|June 28, 1980
[Does bromocriptine act through the autonomic nervous system?]H Allain, D Bentue-Ferrer, D Pape, et al.
Neuropsychobiology|January 1, 1996
The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the ratM A Caldwell, J M Reymann, D Bentue-Ferrer, et al.
Revue Neurologique|January 17, 2003
[Mild Cognitive Impairment: potential therapeutics]H Allain, D Bentue-Ferrer, S Belliard, et al.
Fundamental & Clinical Pharmacology|January 1, 1991
Cardiac beta-adrenoceptor sensitivity and Parkinson's diseaseD Milon, H Allain, D Bentue-Ferrer, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1994
Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free mediumB Saïag, D Milon, D Bentue-Ferrer, et al.
Psychopharmacology|January 1, 1980
The use of bromocriptine for testing central dopaminergic reactivityH Allain, J M Reymann, D Bentue-Ferrer, et al.
Presse Medicale (Paris, France : 1983)|June 18, 1987
[Cerebral edema: intra-cellular or extra-cellular mechanisms?]H Allain, D Bentue-Ferrer, H Bagot, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|February 8, 1980
[Drugs and indications for medical treatment in Parkinson's disease (author's transl)]H Allain, J Van den Driessche, F Menault, et al.
Psychopharmacology|March 22, 1979
Plasmatic renin activity in patients treated with L-dopa and inhibitor of dopa decarboxylase (IDC)H Allain, J Van den Driessche, D Bentue-Ferrer, et al.
Fundamental & Clinical Pharmacology|January 1, 1989
Comparative evaluation of scavenger properties of exifone, piracetam and vinburnineD Bentue-Ferrer, V Philouze, D Pape, et al.
Pageof 4